Table 2. Comparison of clinical characteristics among the three BMI percentile groups.
| Variable | BMI <85th percentile (n=9) |
BMI, 85th–95th percentile (n=27) |
BMI >95th percentile (n=37) |
P-value | P for trend |
|---|---|---|---|---|---|
| Glucose (mg/dL) | 101.1±13.1 | 95.8±5.9 | 99.1±17.2 | 0.495 | 0.684 |
| AST (IU/L) | 27.1±5.0 | 26.0±9.3 | 30.9±13.1 | 0.197 | 0.358 |
| ALT (IU/L) | 23.0±18.2 | 24.8±16.9 | 39.4±29.2 | 0.024* | 0.011 |
| Cholesterol (mg/dL) | 184.9±16.0 | 184.7±31.7 | 180.7±34.8 | 0.861 | 0.725 |
| TG (mg/dL) | 106.0±44.0 | 130.7±73.7 | 152.5±106.4 | 0.326 | 0.168 |
| HDL (mg/dL) | 51.6±10.0 | 51.2±9.5 | 47.5±8.6 | 0.233 | 0.238 |
| LDL (mg/dL) | 100.3±7.8 | 103.4±23.0 | 103.0±24.7 | 0.842 | 0.971 |
| Insulin (µU/mL) | 13.0±5.4 | 14.5±6.2 | 19.9±8.0 | 0.004* | 0.011 |
| CRP (mg/L) | 0.5±0.4 | 1.5±1.4 | 2.3±1.5 | 0.12 | 0.093 |
| Abdomen circumference (cm) | 78.5±4.8 | 86.7±7.7 | 95.4±9.1 | 0.003* | 0.001 |
| VFT (mm) | 27.3±10.5 | 28.5±7.3 | 37.0±11.0 | 0.001* | 0.009 |
| SFT (mm) | 14.4±5.5 | 17.8±5.9 | 23.0±7.9 | 0.009* | 0.009 |
| No. of fatty liver (%) | 2 (22.2) | 7 (25.9) | 21 (56.8) | 0.024† | - |
| HOMA-IR | 3.4±1.9 | 3.5±1.5 | 4.9±2.3 | 0.008* | 0.037 |
Values are presented as mean±standard deviation unless otherwise indicated.
BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TG, triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CRP, C-reactive protein; VFT, visceral fat thickness; SFT, subcutaneous fat thickness; HOMA-IR, homeostasis model assessment for insulin resistance.
*Significantly different from analysis of variance test: P<0.05. †Significantly different from Fisher exact tests: P<0.05